SEP 07, 2021 7:30 AM PDT

Keynote Presentation: The Virus, the Host and the Battle for Survival: How Viruses Interact with the Host Ubiquitin Machinery to Promote Susceptibility or Resistance to Infection

C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

The host antiviral innate immune response involves activation of multiple signaling pathways that result in the production of type I interferons (IFN-I) and inflammatory cytokines, which together control virus infections. However, excessive inflammation and cytokine production can promote exacerbated disease. To achieve the right balance, these signaling pathways are regulated by different molecular processes, including the host ubiquitin system. This system is best known for its function in marking unnecessary proteins for degradation, but can also be used as a weapon against invading pathogens. However, viruses have developed mechanisms to hijack this system for its own use. For example, Zika virus hijacks a host antiviral factor, the E3-ubiquitin ligase TRIM7, which puts an ubiquitin marker on the viral envelope. This ubiquitin on the surface of the virus allows the virus to attach better to receptors expressed in specific cell types, driving the tissue specificity of Zika virus. Therefore, pathogenic viruses can hijack antiviral factors of the ubiquitin system, turning the antiviral functions of ubiquitin into ‘pro-viral’ pathogenic factors. This is a constant battle between the defensive response of the host cell and viruses, resulting in virus evolution and adaptation. In this talk, we will discuss novel molecular mechanism by which E3-ubiquitin ligases of the TRIM family regulate host antiviral pathways, and how different pathogenic viruses hijack the ubiquitin system to enhance virus replication. 

Learning objectives:

1.    Learn mechanisms of regulation of innate antiviral immune signaling that lead to protection against virus infection.

2.    Strategies used by viruses to hijack host antiviral factors to enhance virus replication and pathology


Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
JUN 16, 2022 10:00 AM PDT
JUN 16, 2022 10:00 AM PDT
Date: June 16, 2022 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CEST) Antimicrobial resistance (AMR) has emerged as a major health threat. The FED-AMR project part of the One Health European...
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
Loading Comments...
Show Resources